International Common Stock Total Equity from 2010 to 2024

IBT Stock   698.00  12.00  1.69%   
International Biotechnology's Common Stock Total Equity is decreasing over the years with slightly volatile fluctuation. Overall, Common Stock Total Equity is expected to go to about 10.4 M this year. Common Stock Total Equity is the total value of common stock equity held by shareholders, representing their ownership interest in the company. View All Fundamentals
 
Common Stock Total Equity  
First Reported
2004-08-31
Previous Quarter
10.3 M
Current Value
10.3 M
Quarterly Volatility
2.6 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check International Biotechnology financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among International Biotechnology's main balance sheet or income statement drivers, such as Interest Expense of 2.3 M, Selling General Administrative of 1.1 M or Total Revenue of 21.1 M, as well as many indicators such as . International financial statements analysis is a perfect complement when working with International Biotechnology Valuation or Volatility modules.
  
This module can also supplement various International Biotechnology Technical models . Check out the analysis of International Biotechnology Correlation against competitors.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in International Stock

International Biotechnology financial ratios help investors to determine whether International Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in International with respect to the benefits of owning International Biotechnology security.